Synonyms: Compound 10 [PMID: 38464025] [1] | MS-8709
Compound class:
Synthetic organic
Comment: MS8709 is a first-in-class G9a/GLP PROTAC degrader whose structure was disclosed in preprint [1]. Note that in this context G9a and GLP are histone lysine methyltransferases encoded by EHMT2 and EHMT1 respectively. Excessive activation of the G9a/GLP axis promotes cancer progression, survival, and metastasis, making these targets for oncology drug development. Interaction with the target proteins is achieved by inclusion of the UNC0642 parent inhibitor, and this is linked to a von Hippel Lindau (VHL)-binding moiety to engage with the E3 ligase.
|
|
Bioactivity Comments |
MS8709 promotes degradation of G9a and GLP proteins with in vitro DC50 values of 260 nM and 274 nM respectively. It is bioavailable in mice so is suitable for in vivo studies. |
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|